supra

1 stories · following the connections

Business

Clearside Biomedical, Inc. Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Zuprata™ in Diabetic Macular Edema

By Nasdaq OMXNov 15, 2016, 1:24 PM UTC